Flare-Ups in Crohn’s Disease: Influence of Stress and the External Locus of Control

Dios-Duarte, María José de; Astray, Andrés Arias; Durantez-Fernández, Carlos; Martín, Virtudes Niño; Olea, Elena; Barba-Pérez, María Ángeles; Pérez-Pérez, Lucía; Cárdaba-García, Rosa M.; Barrón, Ana

doi:10.3390/ijerph192013131

Cited by 7 publications

(9 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With respect to the conclusions of our previous research, as well as taking into account the results found regarding the locus of control and stress, it was confirmed that in latency-phase patients with a low external locus of control, both stress and the locus of control influenced the development of outbreaks so that the higher the levels of these two variables, the greater the probability of an outbreak occurring [ 3 , 39 ].…”

Section: Introductionsupporting

confidence: 65%

“…This matter is related to learning about and handling the disease which, based on previous relapse situations, has led these patients to know the importance of controlling and managing their pathology to increase their possibilities of avoiding new flare-ups and hospital admittance. As regards latency-phase Crohn’s patients, our previous studies verified that when the external locus of control was low, this variable, together with stress, were variables that influenced the development of outbreaks [ 3 , 39 ]. Additionally, when patients’ efforts were directed at controlling the pathology following the recommended treatment such as diet, medication, habits and so forth the probability of experiencing a flare-up was reduced.…”

Section: Discussionmentioning

confidence: 99%

“…On the other hand, statistically significant results were found in latency-phase patients as regards the external locus of control and stress. It was also observed that during the latency phase, low levels of stress and external locus of control generated a lower probability of an outbreak [ 3 , 39 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease

et al. 2023

Self Cite

View full text Add to dashboard Cite

(1) Background: Coping includes the specific cognitive processes and behaviours that the patient uses when faced with the stress of living with a chronic disease. Self-efficacy is the knowledge that individuals have about their abilities and their confidence to face a problem or cope with a situation (disease). The aim of this study was to explore the role of coping and self-efficacy in inflammatory bowel disease. (2) Materials and Methods: A total of 92 participants were included (33 had been diagnosed with Crohn’s disease, 23 with ulcerative colitis and 36 were healthy participants). The Coping Strategies Inventory was used to measure which coping strategies were employed, differentiating them as active or passive. The General Self-Efficacy Scale was used to measure self-efficacy. (3) Results: The results indicate that people with inflammatory bowel disease used strategies related to passive coping more than healthy people (mean of 36.39 ± 13.92 vs. 29.77 ± 10.70, p = 0.017). Additionally, people with inflammatory bowel disease used social withdrawal more than healthy participants (mean of 8.30 ± 5.07 vs. 4.47 ± 4.17, p < 0.001). In addition, there are significant differences in emotion-focused engagement coping strategies. People with inflammatory bowel disease used this strategy less than healthy people (mean of 21.77 ± 7.75 vs. 25.03 ± 7.00, p = 0.044). Finally, healthy participants used the emotion-focused disengagement strategy less than those diagnosed with inflammatory bowel disease (mean of 9.81 ± 7.74 vs. 15.61 ± 10.14, p = 0.004). (4) Conclusions: Actions aimed at the development of active coping strategies and patient socialisation must be included in the treatment of inflammatory bowel disease.

show abstract

Section: Introductionsupporting

confidence: 65%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…4) Other . Exacerbation of symptoms in CD is also influenced by strong stress and sleep disturbances, which have been observed during periods of recurrence ( Anthony Sofia et al., 2020 ; de Dios-Duarte et al., 2022 ).…”

Section: Crohn’s Diseasementioning

confidence: 99%

Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?

Duda-Madej,

Stecko,

Szymańska

et al. 2024

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

Crohn’s disease (CD) is a chronic inflammatory disease that most frequently affects part of the distal ileum, but it may affect any part of the gastrointestinal tract. CD may also be related to systemic inflammation and extraintestinal manifestations. Alzheimer’s disease (AD) is the most common neurodegenerative disease, gradually worsening behavioral and cognitive functions. Despite the meaningful progress, both diseases are still incurable and have a not fully explained, heterogeneous pathomechanism that includes immunological, microbiological, genetic, and environmental factors. Recently, emerging evidence indicates that chronic inflammatory condition corresponds to an increased risk of neurodegenerative diseases, and intestinal inflammation, including CD, increases the risk of AD. Even though it is now known that CD increases the risk of AD, the exact pathways connecting these two seemingly unrelated diseases remain still unclear. One of the key postulates is the gut-brain axis. There is increasing evidence that the gut microbiota with its proteins, DNA, and metabolites influence several processes related to the etiology of AD, including β-amyloid abnormality, Tau phosphorylation, and neuroinflammation. Considering the role of microbiota in both CD and AD pathology, in this review, we want to shed light on bacterial amyloids and their potential to influence cerebral amyloid aggregation and neuroinflammation and provide an overview of the current literature on amyloids as a potential linker between AD and CD.

show abstract

“…Because of the decline in its BOLD signal, UC patients are less receptive to happy feelings, which may be linked to the disease's start. Later, the de Dios-Duarte used the Stroop color word interference task to carry out two stress-induced repetition tests in order to look at how CD patients get accustomed to stress (29). The insula, thalamus, cerebellum, and medial temporal lobe (which includes the amygdala and hippocampus) were shown to have aberrant neuronal activity patterns in CD patients.…”

Section: Task-based Fmrimentioning

confidence: 99%

Magnetic Resonance Neuroimaging of Inflammatory Bowel Disease

Tangsujaritvijit

2022

Sci Insights

View full text Add to dashboard Cite

Inflammatory bowel disease (IBD) is a lifelong, relapsing, chronic inflammatory disease of the digestive tract that can be brought on by a number of different etiologies. Studies have shown that patients with IBD also have nervous system involvement in addition to well-known extra-intestinal symptoms like arthritis and iritis, and researchers believe that neurological lesions in patients with IBD may be an important extra-intestinal manifestation. Currently, tentative findings from studies employing magnetic resonance imaging to study the brain structure and function of patients with IBD have been made.

show abstract

Flare-Ups in Crohn’s Disease: Influence of Stress and the External Locus of Control

Cited by 7 publications

References 47 publications

Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease

Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease

Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?

Magnetic Resonance Neuroimaging of Inflammatory Bowel Disease

Contact Info

Product

Resources

About